Drugs / INTERMEDINE
INTERMEDINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00004496 | Feb 1999 → Sep 2003 | acute kidney injury | University of Texas | Completed | No outcome recorded |
Evidence & citations 16 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INTERMEDINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | .alpha.-melanotropin | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | .alpha.-melanotropin (human) | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | .alpha.-melanotropin (ox) | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | .alpha.-melanotropin (sheep) | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | alpha-melanocyte stimulating hormone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004496 ↗ |
| Known as | alpha-MSH | “Patients are infused with alpha-melanocyte stimulating hormone (alpha-MSH) or placebo over 5 minutes.” NCT00004496 ↗ |
| Known as | Intermedin | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | Intermedina | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | Melanophore-stimulating hormone | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | Melanotropin | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | Melanotropin alpha | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | Melantropin | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Known as | N-acetyl-acth(1-13)-amide | ChEMBL registry synonym — accepted as the source's own label CHEMBL214332 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL214332 ↗ |
| Route | Intravenous | “Patients receive a single dose of the MED of alpha-MSH IV over 5 minutes.” NCT00004496 ↗ |